Browse the corpus

REFERENCES American Academy of Pediatrics Committee on Drugs, "'Inactive' Ingredients in Pharmaceutical Products: Update (Subject Review)," Pediatr , 1997, 99(2):268-78. [PubMed 9024461 ] Khan K and Chang J, "Neonatal Abstinence Syndrome Due to Codeine," Arch Dis Child Fetal Neonatal Ed , 1997, 76(1):F59-60. [PubMed 9059191 ] Koren G, Cairns J, Chitayat D, et al, "Pharmacogenetics of Morphine Poisoning in a Breastfed Neonate of a Codeine-Prescribed Mother," Lancet, 2006, 368(9536):704. [PubMed 16920476 ] “Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain,” 6th ed, Glenview, IL: American Pain Society, 2008. Reynolds EW, Riel-Romero RM, and Bada HS, "Neonatal Abstinence Syndrome and Cerebral Infarction Following Maternal Codeine Use During Pregnancy," Clin Pediatr (Phila) , 2007, 46(7):639-45. [PubMed 17704497 ] Spigset O and Hägg S, "Analgesics and Breast-Feeding: Safety Considerations," Paediatr Drugs , 2000, 2(3):223-38. [PubMed 10937472 ] U.S. Food and Drug Administration Center for Drug Evaluation and Research, "FDA Public Health Advisory: Use of Codeine By Some Breastfeeding Mothers May Lead to Life-Threatening Side Effects in Nursing Babies," available at: file://www.fda.gov/cder/drug/advisory/codeine.htm. Topic 13092 Version 42.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [0604-115.25.216.6-A93D27A9D4-S244013.14]